We investigated the hemolytic activity of Escherichia coli strain EC901 carrying plasmid pBJN406 containing genes &A-E involved in expression of the mannose-resistant Dr hemagglutinin, and in its isogenic insertion mutants devised with Tn5, Tn3, and TnphoA. While E. coli BN406 displayed rapid hemolytic activity against equine erythrocytes, insertion mutations in druD and druE, but not in druA, draB, and draC, abolished all hemolytic activity. These data suggest a role for draD and draE in the expression of hemolysis.
Introduction
The Dr hemagglutinin is a fimbrial adhesin expressed by a strain of Escherichiu co/i 075:K5:HP that was isolated from a patient with pyelonephritis [l] . This adhesin belongs to a group of closely related adhesins that include the afimbrial adhesins AFA-I and AFA-III of uropathogenic E. coli and the diarrhea-associated F1845 fimbrial adhesin [2] . Bacteria that express these determinants cause mannose-resistant hemagglutination of human erythrocytes, produce a pattern of diffuse adherence on cultured epithelial cells, and fail to agglutinate Dr(a-) erythrocytes that carry a single amino-acid substitution (Ser '65 to Leu) in the decay accelerating factor (DAF) [3] . Chloramphenicol is a potent inhibitor of receptor binding by the Dr hemagglutinin [4] . Four genes, i.e. druA (encoding structural protein), druC, draD, and draE, have been proposed to be requirements for full mannose-resistant hemagglutinin expression [51.
Our recent investigation revealed the association between the expression of E. co/i hemolytic factors and anemia in pregnant women with pyelonephritis [6] . Lower hematocrit values (< 28) also occurred in patients infected with a-hemolysin-producing strains. Unexpectedly, the significantly decreased hematocrit occurred in four patients infected with LYhemolysin-negative E. coli 075 strains that expressed Dr fimbriae. This observation resulted in the hypothesis that E. cofi 075-associated anemia may occur as a result of unknown hemolytic activity related to the Dr-fimbriae-coding region. Table 1 ). The strains were subcultured three times on LB agar (Sigma) in the presence or absence of chloramphenicol (25 pg ml ' ). Dense bacterial suspensions (optical density 2.5 at 600 nm) were prepared in phosphate-buffered saline (PBS), pH 7.2, with or without 10 mM CaCI,, and washed horse erythrocytes were added to a final concentration of 1% (v/v). The suspensions were incubated at 37°C for 6 h. Samples were taken every 2 h of incubation. These samples were centrifuged at 14000 'pm for 30 s to sediment non-lysed erythrocytes. This short centrifugation did not damage the erythrocytes. The supernatant (200 ~1) was transferred to another tube and was centrifuged at the same speed for 5 min to sediment the bacterial cells.
The absorbance values (Ab) of 150 ~1 of the supernatants were determined in flat-bottomed microtiter plates at 545 nm with a Dynatech Microplate Reader (Dynatech Laboratories Inc., Chantilly, VA) to calculate the amount of released hemoglobin.
In the control experiments, the cY-hemolytic activities of all strains were tested with cultures in liquid medium (Bacto Trypton, Difco-l%, sodium chloride Table 1 E. coli K-12 strains used 0.85 M) supplemented with 10 mM CaCl,. The cultures were incubated for 24 h at 37"C, and samples were taken at regular time intervals. The samples were centrifuged at 10000 'pm for 10 min. Horse erythrocytes washed three times in PBS were added to the supernatants to a final concentration of lo/o, and incubated for 1 h at 37°C. The suspensions were centrifuged for 30 s and the absorbance value of 150 ~1 of the supernatants was determined as described above. Laboratory strain WAM589 [7] , which is E. cofi DHl carrying the a-hemolysin recombinant plasmid pWAM04, kindly donated by Rodney Welch, PhD, (Department of Medical Microbiology and Immunology, University of Wisconsin Medical School, Madison, WI), was used as a positive control. All strains were also tested on solid medium of the same composition supplemented with 1.5% agar and 3% washed horse erythrocytes. Strains subcultured on blood agar plates were incubated at 37°C for 24 h and examined for the presence of a zone of hemolysis. 
In vitro translation of plasmid-encoded proteins

Results and discussion
In the hemolytic assay, E. coli strain BN406 (pBJN406) displayed rapid hemolytic activity after 2 h of incubation (Ab value 0.37) both in the presence and absence of Ca2+. The control E. coli K-12 strains EC901 and EC901 transformed with the vector plasmid pACYC184, were hemolytically inactive during 6 h of incubation (Ab value 0.005) (Fig. 1A) . The genetic organization of the Dr-hemagglutinincoding region and the relative positions of insertional mutations with corresponding hemolytic and hemagglutinating activities are shown in Fig. 2 . Hemolytic activity was expressed by all pBJN406 derivatives obtained by insertional mutagenesis in the draA, druB, and draC regions (Fig. lC, D) . The mutations in draD (pBJN412) and in draE (pBJN413) resulted in a loss of hemolytic activity. However, strain BN417 with the Tn5 insert in the 3' segment of draD was positive. Its lytic activity was delayed by 2 h of incubation, but it eventually reached the value compared to positive strains in 4 h (Fig. 1B) . The analysis of laboratory strains used in this study revealed a lack of hemolytic activity in cell-free supernatants, and in blood agar-grown E. coli host strain EC901 and in EC901 carrying pBJN406 and its derivatives. In contrast, E. coli WAM589 was positive.
Our results show that insertional mutations localized in draE and draD regions (strain BN413 and BN412, respectively) resulted in the disappearance of hemolytic activity. The quantity of the 90-kDa transcription-translation product of draD was substantially reduced (Fig. 3) . Of the two insertional mutants in draD, the hemolytically negative mutant with pBJN412 failed to synthesize the 90-kDa product. In the hemolytically positive strain with pBJN417 approximately the same amount of a truncated polypeptide of about 79 kDa was observed (Fig. 3) . Therefore, both the hemolytically negative BN413 and BN412 mutants were characterized by either a reduction or the disappearance of the druD product.
We conclude that the role of the Dr fimbrillin in hemolytic activity is limited, because three different insertions in the draA region did not abolish hemolysis (Fig. 1D) .
The Dr-hemagglutinin-coding region expressed in E. coli K-12 may be involved in hemolytic activity. Dr-fimbriae-coding region-associated hemolytic activity could be similar to the contact hemolytic activity in Shigella flexneri [8] which is strongly associated with the ability to lyse the phagocytic membrane early during the infection cycle of HeLa cells. Contact-dependent hemolytic activity has also been described for the virulent strain H37Rv of Mycobacterium tuberculosis [9] . It has been suggested that contact cytolysins may be virulence factors important for intracellular pathogens, allowing them to enter the eukaryotic cells, multiply intracellularly, or to escape from membrane-bound vacuoles [S] . The E. coli BN406 hemolytic activity was not present in the culture supernatants and was not affected by Ca"+. It remains to be investigated whether BN406 activity is related to a cell-bound product. The mechanism and the possible role of this activity in the pathogenesis process is currently analysed.
